Background Lung diseases including chronic obstructive pulmonary disease (COPD),
infections like influenza, acute respiratory distress syndrome (ARDS), asthma and …

Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease characterized by
progressive loss of pulmonary function. Drug-induced interstitial lung disease has been …

Emergence of SARS-CoV-2 causing COVID-19 has resulted in hundreds of thousands of
deaths. In search for key targets of effective therapeutics, robust animal models mimicking …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapidly spread around the
globe after its emergence in Wuhan in December 2019. With no specific therapeutic and …

The expanding pandemic of coronavirus disease 2019 (COVID-19) requires the
development of safe, efficacious and fast-acting vaccines. Several vaccine platforms are …

Numerous compounds have shown efficacy in limiting development of pulmonary fibrosis
using animal models, yet few of these compounds have replicated these beneficial effects in …

Background Within one year after its emergence, more than 108 million people acquired
SARS-CoV-2 and almost 2· 4 million succumbed to COVID-19. New SARS-CoV-2 variants of …

Epidemiological studies have revealed positive correlation between particulate matter with
an aerodynamic diameter of< 2.5 µm (PM 2.5) and pulmonary fibrosis (PF). As etiology and …

Idiopathic pulmonary fibrosis (IPF) is a chronic progressive degenerative lung disease
leading to respiratory failure and death. Although anti-fibrotic drugs are now available for …

X-ray computed tomography is a reliable technique for the detection and longitudinal
monitoring of pulmonary nodules. In preclinical stages of diagnostic or therapeutic …